Varenicline for the management of cannabis use disorder: A systematic review.
INTRODUCTION Cannabis use disorder (CUD) is one of the highest prevalence mental health conditions globally. Psychosocial treatments for CUD have modest efficacy. There are currently no approved adjunctive pharmacological approaches for CUD. Varenicline, a nicotinic receptor partial agonist approved for use in smoking...